ICPerMed "Best Practice in Personalised Medicine" Recognition 2019

The International Consortium for Personalised Medicine (ICPerMed) has published the announcement of their "Best Practice in Personalised Medicine" Recognition 2019, which aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine. This second edition is open to candidates worldwide, who have published scientific papers and/or developed best practice strategies in the field of personalised medicine between January 1st, 2017 and October 31st 2018. The deadline for proposal submission is the 21st January 2019.

The successful applicants (maximum number of three) will be invited to the 2019 ICPerMed Workshop and will be given the opportunity to present their results during a plenary session. In addition, they will receive support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of 500 €.

The applications submitted should cover at least one of the three defined topics linked to “Personalised Medicine for all citizens and patients within sustainable health systems, including models to facilitate investment in disease prevention and therapy research”.

These best practice examples can consist of one or several of the following:

  • Scientific paper focused on novel approaches for the implementation of personalised medicine;
  • Training programmes for health personnel, increasing the level of awareness on the potential of personalised medicine;
  • Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organisations, academic management, medical research, Health Care and SME), for the implementation of personalised medicine, including ELSI activities.

More information on the ICPerMed Recognition 2019:



The International Consortium of Personalized Medicine (ICPerMed) was established in November 2016 and comprises over 40 European and international members representing research and health ministries as well as funding agencies, including the European Commission as observer. The aim of ICPerMed is to boost personalised medicine by an enhanced coordination and alignment of research activities.

ANR is implicated in ICPerMed as well as in the ICPerMed Coordination and Support Action (ICPerMed Secretariat; CSA; 2016-2020) and ERA PerMed, the ERA Net on Personalised Medicine.